Fowler Wyche 4
4 · ZIOPHARM ONCOLOGY INC · Filed Dec 13, 2017
Insider Transaction Report
Form 4
Fowler Wyche
Director
Transactions
- Tax Payment
Common Stock
2017-12-11$4.20/sh−15,800$66,360→ 146,070 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-11−20,000→ 0 totalExercise: $2.73Exp: 2017-12-12→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2017-12-11$2.73/sh+20,000$54,600→ 161,870 total
Footnotes (2)
- [F1]Represents 13,000 shares withheld to pay exercise price and 2,800 shares withheld to pay tax withholding obligations.
- [F2]6,667 shares vested on each of 12/12/08 and 12/12/09; 6,666 shares vested on 12/12/10.